fundvisualizer.com

MainStay WMC Intl Research Eq CMYICX

Performance (before sales charge)

As of 10/31/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2023
Stock
1.49%
Non-U.S. Stock
97.90%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.60%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2023

Basic materials

6.33%

Consumer cyclical

9.60%

Financial services

21.13%

Real estate

3.23%

Consumer defensive

7.32%

Health care

12.86%

Utilities

3.98%

Communication services

6.13%

Energy

5.69%

Industrials

11.15%

Technology

11.71%

Top 10 holdings

As of 09/30/2023

Taiwan Semiconductor Manufacturing Co Ltd ADR
2.57%
Shell PLC
2.24%
Unilever PLC
2.24%
Tencent Holdings Ltd
2.02%
BP PLC
1.87%
Novartis AG Registered Shares
1.74%
AstraZeneca PLC
1.65%
HSBC Holdings PLC
1.63%
Pernod Ricard SA
1.61%
Reckitt Benckiser Group PLC
1.60%
Fund assets

$146.4 Million

Share class

C

Morningstar category

Foreign Large Blend

Expense ratio

2.25%

Investment objective

Foreign Stock

Documents